Cargando…
Mechanism of mutant calreticulin-mediated activation of the thrombopoietin receptor in cancers
Myeloproliferative neoplasms (MPNs) are frequently driven by mutations within the C-terminal domain (C-domain) of calreticulin (CRT). CRT(Del52) and CRT(Ins5) are recurrent mutations. Oncogenic transformation requires both mutated CRT and the thrombopoietin receptor (Mpl), but the molecular mechanis...
Autores principales: | Venkatesan, Arunkumar, Geng, Jie, Kandarpa, Malathi, Wijeyesakere, Sanjeeva Joseph, Bhide, Ashwini, Talpaz, Moshe, Pogozheva, Irina D., Raghavan, Malini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085772/ https://www.ncbi.nlm.nih.gov/pubmed/33909030 http://dx.doi.org/10.1083/jcb.202009179 |
Ejemplares similares
-
Effects of calreticulin mutations on cell transformation and immunity
por: Desikan, Harini, et al.
Publicado: (2023) -
The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin
por: Varghese, Leila N., et al.
Publicado: (2017) -
Exploring the Molecular Landscape of Myelofibrosis, with a Focus on Ras and Mitogen-Activated Protein (MAP) Kinase Signaling
por: Reynolds, Samuel B., et al.
Publicado: (2023) -
Tumor necrosis factor related apoptosis inducing ligand (TRAIL) regulates deubiquitinase USP5 in tumor cells
por: Potu, Harish, et al.
Publicado: (2019) -
Downregulation of SOX2 by inhibition of Usp9X induces apoptosis in melanoma
por: Potu, Harish, et al.
Publicado: (2021)